Policy briefings
- Unpacking polygenic scores
- Polygenic score analysis: the test pipeline
- Application of polygenic scores in healthcare
- Regulating polygenic score devices and tests
- The path to using polygenic scores in healthcare
- The European Health Data Space
- Host genomics for better infectious disease treatment
- Gene editing animals for organ transplants to humans
- Long-read sequencing: Clinical applications and implementation
- Clinical long-read sequencing
- Precision medicine for inflammatory bowel disease
- Data intermediaries for health
- CAR-T cell therapies
- Phage therapy to treat AMR infections
- Antisense oligonucleotide therapies
- Age-related macular degeneration and genomics
- Functional genomics
- Functional genomics in clinical medicine
- Unpicking the impact of the GDPR on genomic data
- Putting AI to work in genomic medicine
- Black box medicine and transparency
- Somatic genome editing: ethics and regulation
- Somatic genome editing: promise and practicalities
- Citizen generated data – an opportunity for public health?
- Somatic genome editing: an overview
- Citizen generated data: the ethics of remote patient monitoring
- What is an algorithm?
- What is long read sequencing?
- RNA vaccines: an introduction
- Long read sequencing: Ready for the clinic?
- Legal liability for machine learning in healthcare
- What is citizen generated data?
- What is the GDPR?
- What is the IVDR?
- Linking and sharing routine health data for research in England
- ctDNA technology in lung cancer: personalised healthcare in action
- Circulating tumour DNA technology: the future of cancer management?
- Delivering an effective infectious disease genomics service
- Protecting patients from healthcare associated infections: a role for genomics
- Genomics for infection control: meeting local and national needs
- Phenotyping patients for genomic diagnostics
- One health genomics - why animal diseases matter for human health
- Genomics and the management of antimicrobial resistance: current successes and future challenges
- Array CGH testing for learning disability- when is it worth it?
- Sharing clinical genomic data for better diagnostics
- Leading the way: driving the delivery of pathogen genomics into practice
- Setting the right standards for clinical genome analysis
- The impact of genomic sequencing technologies on patient pathways
- Defining the role of a bioinformatician
- Beating the bugs: the pathogen genomics revolution
- Genomics and the boundary between research and clinical care and treatment
- The genomic contribution to diabetes
- Clinical whole genome analysis: delivering the right diagnosis
- ELSI and the implemention of WGS/WES in clinical practice